Dr. Rakhi Khanduri Honoured With Two Prestigious National Fellowships

Published on: February 16, 2026

Dr. Rakhi Khanduri of the Himalayan Institute of Medical Sciences (HIMS), Jollygrant, has achieved a remarkable professional milestone by receiving fellowships from two of India’s most esteemed respiratory medicine bodies—the Indian Chest Society (ICS) and the National College of Chest Physicians (NCCP). The honour was conferred during NAPCON 2025, a leading national conference of respiratory specialists held in Patna. This recognition highlights her sustained contribution to respiratory medicine and clinical research.

>Dr. Khanduri noted that receiving a fellowship from a professional medical society is regarded as one of the highest distinctions in the field. Such honorary recognition is awarded only to specialists who demonstrate exceptional expertise, academic excellence, and long-standing commitment to research and patient care. Her selection for fellowships from both ICS and NCCP reflects her dedication to advancing pulmonary healthcare and her consistent contributions to scientific inquiry and clinical practice.

Expressing gratitude for the recognition, Dr. Khanduri described the honour as a source of motivation to continue serving patients with greater commitment and compassion. She emphasized that the fellowship reinforces her resolve to contribute meaningfully to medical research and to the improvement of respiratory healthcare services.

The achievement also brings pride to HIMS, Jollygrant, further strengthening its reputation for excellence in medical education, research, and specialized healthcare services. Dr. Khanduri’s accomplishment stands as an inspiration for young medical professionals and reflects the institution’s ongoing commitment to advancing healthcare through knowledge, research, and dedicated service to society.

1
2
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.